Lower levels of SIRT1 compromise the deacetylation-mediated activation of downstream autophagy proteins (e.g., ATG5, ATG7, and LC3) [142], which may also contribute to autophagy impairment in AD. Here, MAP1LC3A is linked to Alzheimer disease.